Katharine M. Woessner, MD, is the head of the Division of Allergy, Asthma and Immunology at Scripps Clinic Medical Group in San Diego, US.
What is the prevalence of nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (NERD) among patients with asthma?
The prevalence is ~7% if you take all asthmatics in general, but it’s overrepresented if you look at severe asthmatics who also have nasal polyps—then it goes up to ~30%.